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Background:
Plasmodium vivax is the most common species causing malaria outside Africa with
approximately 13.8 million reported cases worldwide. More than 80% of P.
vivax malaria cases are estimated to occur in Pakistan, India and Indonesia (WHO
2015) . P.vivax is associated with increased morbidity but reduced mortality when
compared to Plasmodium falciparum. Recently, studies from Indonesia, Papua New
Guinea, Brazil, India, and Pakistan have shown that P.vivax, can independently prove
fatal or result in severe morbidity. The most common complications of vivax malaria
reported globally are anemia and non-cardiogenic pulmonary oedema/ acute
respiratory distress syndrome. Other complications are severe thrombocytopenia,

1

pancytopenia, jaundice, splenic rupture, acute renal failure and rarely cerebral
involvement.
Cerebral malaria is a known complication of P. falciparum with over 575,000 cases
leading to neurological, behavioural and cognitive defects reported annually.(1)
However, cerebral malaria due to P. vivax mono infection is rarely reported. Malaria
remains an endemic disease in Pakistan with an estimated health care burden of 1.6
million cases annually with P. vivax accounting for 67% of reported cases. We
report a severe P. vivax infection with cerebral involvement in a child.

Case Report
A nine-year old boy presented to the emergency department of The Aga Khan
University Hospital (AKUH) with a 3-day history of high grade fever accompanied
by projectile vomiting and abnormal behaviour. A day prior to his admission he
developed generalized tonic-clonic seizures associated with dizziness and
unconsciousness. He had a coma score of 5/15 on presentation with a tachycardia
(167/min), tachypnoea (70 breaths/min), oxygen saturation of 92%, blood pressure of
133/87 mm of Hg and a temperature of 38oC. There was hypertonia in all limbs. The
rest of the physical examination was normal. The full blood count showed anaemia
(Hb 94g/L), a leucocytosis (13.1x106/mL, neutrophils 75% and monocytes 8%) and
normal platelet count (304x106/mL). A cerebral CT scan showed oedema with
increased intracranial pressure. Thick and thin peripheral smear with Giemsa stain
was suggestive of P. vivax with 1-10 per 100 high power fields. Stained blood films
were also independently reviewed by an external expert parasitologist who confirmed
the original diagnosis. Polymerase chain reaction (PCR) and an immunochromatography test (ICT) definitely excluded P. falciparum infection. Prothrombin
time and activated partial thrombin time were in the normal range, and the direct
antiglobulin test was negative. Although no lumbar puncture was performed empirical
therapy for bacterial and viral meningitis was initiated. Initially Vancomycin,
Meropenem, Acyclovir, steroids and anticonvulsants were started in emergency.
The patient was mechanically ventilated. He required vasopressor support with
norepinephrine. Blood cultures and urine cultures were all negative, Antibiotics were
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deescalated and stopped as blood film confirmed malarial parasite P.vivax and started
with artemether lumefantrine. On the third day, he developed high urine output and
hyponatremia secondary which was managed with fludrocortisone. On presentation
his sodium levels were 145mmol/L (normal ranges 135-145 mmol/L) and dropped to
125mmol/L on third day. His sodium level was corrected to 135 in 72 hours and child
gained consciousness. The GCS score improved to 15/15 and he was extubated on the
sixth day of admission and discharged on the ninth day.Post-treatment microscopy
revealed blood films negative for P.vivax.

Discussion
P. vivax malaria has historically been termed, ‘Benign Tertian Malaria’ but it is
increasingly felt that this is an erroneous label. Rossle in 1921 described a lethal
cerebellar haemorrhage in a 21-year old soldier suffering a vivax infection
(3). Patients presenting with cerebral symptoms such as acute febrile encephalopathy,
raised intracranial pressure, intracerebral haemorrhage, hemiparesis, aphasia and
seizures following vivax malaria have been reported previously (4, 5).
Several cases of cerebral malaria attributed to P.vivax infection have been reported in
recent years, especially in Asia and South America. This may be due to an overall
increase in P. vivax malarial infections. Most of these cases have been reported from
India where P. vivax is the predominant species (6). Although the mechanism by
which P. vivax causes cerebral malaria is not fully understood, a suggested
pathogenesis is the sequestration of infected erythrocytes in cerebral microvascular
beds(7).
In our case, the peripheral blood smears with Giemsa stain were repeatedly performed
and parasitaemia remained low. Immuno-chromatography testing showed no trace
of P. falciparum, and PCR helped confirm mono-infection by P. vivax. Advances in
molecular and serodiagnosis of malaria parasites have increased the sensitivity and
specificity, and so the substantial accuracy, of diagnosis of P. vivax. (8, 9)
Physicians must be aware of the aggressive pathology of severe P. vivax infections
and institute prompt and accurate diagnosis in treatment. Furthermore, an increasing
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incidence of severe malaria cases due to P. vivax are already placing a huge burden
on an already strained healthcare system.
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